These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 10493981)
1. The apoptosis-inducing activity of the two protein phosphatase inhibitors, tautomycin and thyrsiferyl 23-acetate, is not due to the inhibition of protein phosphatases PP1 and PP2A (review). Kikuchi K; Shima H; Mitsuhashi S; Suzuki M; Oikawa H Int J Mol Med; 1999 Oct; 4(4):395-401. PubMed ID: 10493981 [TBL] [Abstract][Full Text] [Related]
2. Different moieties of tautomycin involved in protein phosphatase inhibition and induction of apoptosis. Kawamura T; Matsuzawa S; Mizuno Y; Kikuchi K; Oikawa H; Oikawa M; Ubukata M; Ichihara A Biochem Pharmacol; 1998 Apr; 55(7):995-1003. PubMed ID: 9605423 [TBL] [Abstract][Full Text] [Related]
3. Thyrsiferyl 23-acetate and its derivatives induce apoptosis in various T- and B-leukemia cells. Matsuzawa S; Kawamura T; Mitsuhashi S; Suzuki T; Matsuo Y; Suzuki M; Mizuno Y; Kikuchi K Bioorg Med Chem; 1999 Feb; 7(2):381-7. PubMed ID: 10218832 [TBL] [Abstract][Full Text] [Related]
4. Effect of inhibitors of protein phosphatase 1 and 2A on erythroid colony formation: an investigation of the specificities of inhibitors. Zhang W; Tamura J; Sakuraya M; Naruse T; Kubota K J Int Med Res; 2001; 29(2):114-8. PubMed ID: 11393344 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways. Chatfield K; Eastman A Biochem Biophys Res Commun; 2004 Oct; 323(4):1313-20. PubMed ID: 15451440 [TBL] [Abstract][Full Text] [Related]
6. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. Favre B; Turowski P; Hemmings BA J Biol Chem; 1997 May; 272(21):13856-63. PubMed ID: 9153244 [TBL] [Abstract][Full Text] [Related]
7. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases. Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855 [TBL] [Abstract][Full Text] [Related]
8. Effects of modification of the hydrophobic C-1-C-16 segment of tautomycin on its affinity to type-1 and type-2A protein phosphatases. Takai A; Tsuboi K; Koyasu M; Isobe M Biochem J; 2000 Aug; 350 Pt 1(Pt 1):81-8. PubMed ID: 10926829 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of specific protein phosphatase inhibitors, tautomycin and tautomycetin toward structure-activity relationship study. Oikawa H Curr Med Chem; 2002 Nov; 9(22):2033-53. PubMed ID: 12369869 [TBL] [Abstract][Full Text] [Related]
10. Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1. Mitsuhashi S; Matsuura N; Ubukata M; Oikawa H; Shima H; Kikuchi K Biochem Biophys Res Commun; 2001 Sep; 287(2):328-31. PubMed ID: 11554729 [TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Resjö S; Göransson O; Härndahl L; Zolnierowicz S; Manganiello V; Degerman E Cell Signal; 2002 Mar; 14(3):231-8. PubMed ID: 11812651 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein. Takai A; Sasaki K; Nagai H; Mieskes G; Isobe M; Isono K; Yasumoto T Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):657-65. PubMed ID: 7702557 [TBL] [Abstract][Full Text] [Related]
13. Role of protein phosphatases in cyclic AMP-mediated stimulation of hepatic Na+/taurocholate cotransport. Mukhopadhyay S; Webster CR; Anwer MS J Biol Chem; 1998 Nov; 273(45):30039-45. PubMed ID: 9792726 [TBL] [Abstract][Full Text] [Related]
14. The selective inhibition of phosphatases by natural toxins: the anhydride domain of tautomycin is not a primary factor in controlling PP1/PP2A selectivity. Liu W; Sheppeck JE; Colby DA; Huang HB; Nairn AC; Chamberlin AR Bioorg Med Chem Lett; 2003 May; 13(9):1597-600. PubMed ID: 12699763 [TBL] [Abstract][Full Text] [Related]
15. Thyrsiferyl 23-acetate is a novel specific inhibitor of protein phosphatase PP2A. Matsuzawa S; Suzuki T; Suzuki M; Matsuda A; Kawamura T; Mizuno Y; Kikuchi K FEBS Lett; 1994 Dec; 356(2-3):272-4. PubMed ID: 7805852 [TBL] [Abstract][Full Text] [Related]
16. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors. Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807 [TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A. Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676 [TBL] [Abstract][Full Text] [Related]
18. A cyclophilin-regulated PP2A-like protein phosphatase in thylakoid membranes of plant chloroplasts. Vener AV; Rokka A; Fulgosi H; Andersson B; Herrmann RG Biochemistry; 1999 Nov; 38(45):14955-65. PubMed ID: 10555977 [TBL] [Abstract][Full Text] [Related]
19. A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A. Gupta V; Ogawa AK; Du X; Houk KN; Armstrong RW J Med Chem; 1997 Sep; 40(20):3199-206. PubMed ID: 9379439 [TBL] [Abstract][Full Text] [Related]